FDA approves bladder cancer treatment by Culver City company
by Los Angeles Times
Los Angeles Times— The Food and Drug Administration on Monday approved a new treatment for a type of bladder cancer. The treatment, which will be sold under the brand name Anktiva, is intended for some patients suffering from certain types of non-muscle invasive bladder cancer, according to an FDA statement announcing the approval. News of the FDA action was first reported by Reuters, which said, "The therapy works by activating types of disease fighting white blood cells called natural killer (NK) cells and...
The Independent—New targeted treatment approved for children with brain cancer. The drugs improve children’s response rate to treatment and survival time without the disease getting worse.
WION—Global impact of breast cancer | Disparities in breast cancer treatment addressed. With the estimated 2.3 million new cases of breast cancer in 2022, roughly one in every 9 cancers for both sexes diagnosed globally was breast cancer: WHO.
NL Times—Utrecht city council approves plans to make the whole city paid parking. The Utrecht city council has agreed to apply paid parking throughout the city. This will happen neighborhood by neighborhood and will take 12 years. Before this, it was only in busy areas where you had to pay for parking. Now, there is a plan to have the whole city paid for parking starting in 2034. alderperson of mobility Lot van Hooijdonk called it “A milestone” while she is also aware of the unpopularity of the decision. However, it is essential for the city to prevent “tens of thousands of...